Nuvalent (NUVL) Reiterated at Buy by Stifel on Ph1/2 ALKOVE-1 study Data

June 1, 2026 7:35 AM

Stifel analyst Laura Prendergast reiterated a Buy rating and $135.00 price target on Nuvalent (NASDAQ: NUVL).The analyst commented, "NUVL presented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found